§ Funding Round
Series B funding round for NOCD raising $34M in January 2023
Series B funding round for NOCD raising $34M in January 2023
| Investor | Firm Type | Partner |
|---|---|---|
7wire VenturesLEAD | Organization | — |
Advent Life Sciences | — | — |
Draper Associates | — | — |
| Organization | — | |
General Catalyst | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | curtis chambers | |
craig ciminiLEAD | Angel | craig cimini |
| Organization | — | |
F-Prime Capital | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$84M
Top Valuation
-
NOCD raised $34M in a Series B round.
The round was announced on 01/01/23.
The round was led by 7wire Ventures, craig cimini.
